From: Are microRNAs suitable biomarkers of immunity to tuberculosis?
Study | Study type | Study group sizes | Upregulated | Downregulated | Overlap of differentially expressed miRNAs |
---|---|---|---|---|---|
Abd-El-Fattah et al. 2013 [23] | Custom array for unspecified number of miRNAs (single samples) | 29 TB, 37 healthy controls (no definition) | miR-182 miR-197 | Â | miR-197 |
Qi et al. 2012 [22] | Array for 667 miRNAs (pooled for study groups) | 30 TB, 65 healthy controls (negative chest X-ray and IGRA, free from clinical symptoms of infection) | miR-361-5p miR-889 miR-576-3p | Â | |
miR-25 miR-590-5p miR-885-5p | |||||
Miotto et al. 2013 [24] | Array for 671 miRNAs (pools of 10 individuals) | 154 pulmonary TB, 105 healthy controls (negative IGRA or TST, no risk-factors for LTBI, no clinically significant condition) over 2 cohorts | miR-148a miR-16 miR-192 miR-193a-5p miR-25 miR-365 miR-451 miR-532-5p miR-590-5p miR-660 miR-885-5p miR-223a miR-30e | let-7e miR-146 | |
miR-365 | |||||
Fu et al. 2011 [20] | Array for 1,223 miRNAs (pooled for study groups) | 75 TB, 52 healthy controls (defined as `free of active and latent TB') | miR-93a miR-29a | miR-3125 | |
miR-483-5p miR-22 | |||||
Zhang et al. 2013 [25] | Deep sequencing (20 individual samples for each group) | 128 pulmonary TB, 108 healthy controls (no definition) | miR-378 miR-483-5p miR-22 miR-29c | miR-101 miR-320b |